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Abstract
Accurate molecular surveillance is important in monitoring the dynamics of Streptococcus pneumoniae. A prospective study was con-
ducted to collect invasive isolates of S. pneumoniae from children for genetic analysis from January 2004 to December 2006 in Taiwan.
PCRs were performed to detect the zmpC and zmpD genes, both encoding a metalloprotease virulence factor in pneumococci, among
these invasive isolates. During the study period, 68 invasive isolates of S. pneumoniae were obtained for analysis. Serotype 14 was
the most common type isolated from children with invasive disease and was signiﬁcantly associated with pneumonia (OR 3.1;
95% CI] 1.1–8.8; p 0.035). Serotype 23F was signiﬁcantly associated with bacteraemia (OR 7.5; 95% CI 1.8–31.3; p 0.006). The seven-
valent conjugate vaccine covered 83.8% of invasive isolates, but non-vaccine serotypes were more frequently isolated from patients with
underlying diseases than from patients without underlying diseases (p 0.007 by Fisher’s exact test). Clonal complexes related to interna-
tional clones Spain23F ST81, Spain6B ST95, England14 ST9, Taiwan19F ST236, Taiwan23F ST242 and Colombia23F ST338 accounted for
52.9% of invasive isolates. Dissemination of the penicillin-resistant clones ST876, ST46, ST76 and ST2889, which were ﬁrst identiﬁed in
Taiwan, was also found; 1.5% of these invasive isolates carried the zmpC gene, and 47.1% of these invasive isolates carried the zmpD
gene. In conclusion, the spread of certain international clones and some domestic antibiotic-resistant clones resulted in invasive diseases
among Taiwanese children.
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Introduction
In recent decades, the increase in the number of Streptococ-
cus pneumoniae strains resistant to b-lactam antibiotics and
other classes of antimicrobials has complicated the treatment
of pneumococcal infection [1]. The seven-valent pneumococ-
cal conjugate vaccine has been licensed for use in children in
the USA since 2000, and has led to the hope of preventing
pneumococcal disease. Since the introduction of the seven-
valent conjugate vaccine, invasive pneumococcal disease
caused by the vaccine serotypes and the spread of multiresis-
tant pneumococci have been dramatically reduced in the
USA [2,3]. However, invasive pneumococcal disease caused
by non-vaccine serotypes has been increasing [4,5]. In the
era of the pneumococcal conjugate vaccine, understanding
the genetic background of pneumococci offers important
information for the surveillance of pneumococcal disease and
valuable insights into the evolution of S. pneumoniae.
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Studies of pneumococcal epidemiology have revealed that
certain serotypes, such as serogroups/serotypes 1, 7, 4, 18,
9, and 14, are more invasive than other serogroups/
serotypes [6]. Although capsular serotype is considered to
be an important determinant of the invasive potential of
pneumococci, the genetic background, in addition to capsular
serotype, plays a critical role in pneumococcal virulence [7].
ZmpC and ZmpD are both metalloprotease virulence factors
in S. pneumoniae [8,9]. ZmpC has the ability to cleave human
matrix metalloproteinase 9 [8] and cause the shedding of
syndecan-1 ectodomains of host cells [10]. ZmpD, encoding
a putative metalloproteinase located downstream of the IgA
protease, has been identiﬁed as a virulence factor in G54
(a clinical isolate of serotype 19F) by a large-scale genomic
approach, although TIGR4 (a clinical isolate of serotype 4)
and R6 (an uncapsulated strain of D39) do not contain it
[11]. However, the function of ZmpD and its substrate
remains unclear. Previous ﬁndings suggested that ZmpC and
ZmpD were not ubiquitous in pneumococci, and limited evi-
dence indicated that ZmpC and ZmpD might be associated
with speciﬁc serotypes or lineages [8,11] . In Taiwan, the
seven-valent conjugate pneumococcal vaccine has been avail-
able since October 2005. Only 8.4% of children below
5 years of age had received one or more doses of the vac-
cine in 2006 (data provided by Wyeth). In the present study,
we characterized the genetic structure of S. pneumoniae
isolates causing invasive disease in children, and performed
PCR analysis to study the prevalence rates of the zmpC gene
and the zmpD gene among these invasive isolates.
Materials and Methods
Bacterial isolates
From January 2004 to December 2006, 69 children aged
below 15 years with invasive S. pneumomiae were treated at
ﬁve medical centres in Taiwan. In total, 70 isolates were col-
lected from the 69 children during the study period; one
patient with congenital cerebrospinal leaks had two episodes
of meningitis and was included twice. The hospitals com-
prised: National Taiwan University Hospital, Taipei (34 iso-
lates); Taipei Medical University–Wanfang Hospital, Taipei
(four isolates); China Medical College Hospital, Taichung
(nine isolates); Buddist Tzu Chi General Hospital, Hualien
(three isolates); and Chang-Gung Memorial Hospital,
Kaohsiung (20 isolates). One isolate causing lobar pneumonia
and one isolate causing empyema were not available; the
remaining 68 isolates were subjected to microbiological anal-
ysis. Excluding four isolates from Taipei Medical University–
Wanfang Hospital, the other 64 isolates formed part of our
other investigation [12]. The medical records of patients
with invasive pneumococcal disease were reviewed. A pneu-
monic isolate was deﬁned as a positive blood culture or
positive pleural ﬂuid culture from a child with a consolidation
pattern upon chest X-ray. A meningitis isolate was deﬁned
as a positive cerebrospinal ﬂuid culture from a child with the
diagnosis of meningitis. Primary bacteraemia without focus
was deﬁned as a positive blood culture from a child with
fever but without a focal lesion.
Antimicrobial susceptibility testing
The MICs of penicillin and cefotaxime for 68 S. pneumoniae
isolates were determined by the broth dilution method, and
the results were interpreted according to CLS guidelines
[13]. The MICs of vancomycin, amoxycillin–clavulanate and
erythromycin were determined [13].
Serotyping
The serotypes of isolates were determined using the capsu-
lar swelling method (Quellung reaction). All antisera were
obtained from the Statens Seruminstitut (Copenhagen,
Denmark).
Multilocus sequence typing (MLST)
MLST was performed as previously described [14]. New MLST
proﬁles were submitted to the curator at http://spneumo-
niae.mlst.net for new sequence type (ST) numbers. The clonal
complex (CC) and the founder ST within the CC were
assigned using the eBURST algorithm [15]. PCR for the zinc
metalloprotease C (zmpC) gene and the zinc metalloprotease
D (zmpD) gene was performed as previously described [8,11].
Brieﬂy, we used two pairs of primers (GM12 and GM13;
GM14 and GM15) to detect the presence of the zmpC gene
[8,11], and another two pairs of primers (GM192 and GM9;
GM192 and GM191) to detect the presence of the zmpD gene
[11]. ZmpD genes in each CC or ST positive for this gene were
sequenced by using PCR with primers 5¢-GTGTTTACTAT-
TAGGAAATAAAAAGTG-3¢ (upper-zmpD) and 5¢-GGATG-
GTTTTTAGATTAGGGG-3¢ (down-zmpD). The GenBank
accession number for ZmpD of isolate 7301 was AB457845,
that for ZmpD of isolate WF39 was AB457846, and that for
ZmpD of isolate BT20 was AB457847. DNA sequences and
amino acid sequences were analysed with the ClustalW pro-
gram (http://www.ebi.ac.uk/clustal).
Statistical analysis
Chi-square test or Fisher’s exact test was used for categori-
cal variables to test the signiﬁcance of differences between
groups. A p-value of <0.05 was considered to be statistically
signiﬁcant. ORs and 95% CIs were calculated to identify indi-
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vidual serotypes relative to all other serotypes in the sample
and serotypes associated with pneumonia or bacteraemia
without focus. All analyses were performed using the SPSS
statistical package (SPSS Inc., Chicago, IL, USA).
Results
Among the 69 children, 32 had pneumonia, 25 had bactera-
emia without focus, six had seven episodes of meningitis, two
had both lobar pneumonia and meningitis, one had an infected
haematoma, one had mastoiditis, one had pyomyositis, and
one had septic arthritis. Among the 68 isolates, 41 were from
blood, 14 from pleural ﬂuid, nine from cerebrospinal ﬂuid,
and four from other sterile sites. There were 40 boys and 29
girls, with a mean age of 40.2 months (median, 41.5 months;
range, 7–114 months). Nine patients had underlying diseases
that were presumed to place them at high risk for pneumo-
coccal disease; one had congenital immunodeﬁciency, four
had cyanotic heart disease, one had a congenital cerebrospi-
nal leak, one had nephrotic syndrome, and two had received
immunosuppressive therapy. One patient with a congenital
cerebrospinal leak who had two episodes of meningitis was
included twice in the analysis; the two episodes were both
caused by serotype 6B isolates, but with different genotypes.
The most prevalent serogroup/serotype was 14 (n = 23,
33.8%), followed in descending order by 23F (n = 12, 17.6%),
6B (n = 11, 16.2%), 19F (n = 9, 13.2%), 3 (n = 4, 5.9%), 15
(n = 3, 4.4%), 23A (n = 2, 2.9%), 9V (n = 1, 1.5%), 6A (n = 1,
1.5%), 33 (n = 1, 1.5%), and 18C (n = 1, 1.5%) (Table 1). The
coverage rate of the seven-valent conjugate vaccine was
83.8% (57/68). Non-vaccine serogroups/serotypes were more
frequently isolated from patients with underlying diseases
than from patients without underlying diseases (p 0.004 by
Fisher’s exact test, 5/9 vs. 6/58).
In total, ﬁve new STs (ST1170, ST2890, ST2891, ST2921,
and ST2889) were identiﬁed. We grouped the isolates into
different CCS, using the results of MLST. CC13 serotype 14
was the largest (Table 2); ST13 was the predicted founder of
this CC. Notably, ST13 is a single-locus variant (SLV) of ST9,
which represents the international clone England14 ST9.
CC236 serotype 19F isolates made up the second largest
CC. ST236 represented international clone Taiwan19F
ST236. The third largest cluster was ST876, representing
serotype 14 (eight isolates). CC166 contained one isolate of
ST166 expressing serotype 9V and another isolate of ST1225
expressing serotype 14. ST1225 is a double-locus variant of
ST166, and ST166 is an SLV of Spain9V ST156.
Association between serotype/ST and disease type
Among the 25 cases of bacteraemia, serotype 23F accounted
for 36% (9/25) of isolates, comprising ﬁve isolates of CC81,
three isolates of ST242, and one isolate of CC338 (Table 1).
As compared with other serotypes, serotype 23F was signiﬁ-
cantly associated with bacteraemia (OR 7.5; 95% CI 1.8–
31.3; p 0.006).
There were 34 cases of pneumonia, from which 32 iso-
lates from 32 patients were available for serotyping and
MLST analysis. Isolates of serotype 14 accounted for
46.9% (15/32) of the isolates causing pneumonia, which
included eight isolates of CC13, ﬁve isolates of CC876,
one isolate of CC166, and one isolate of ST46. As com-
pared with other serotypes, serotype 14 was signiﬁcantly
associated with pneumonia (OR 3.1; 95% CI 1.1–8.8;
p 0.035).
There were nine cases of meningitis. Isolates of sero-
type 6B accounted for 44.4% (4/9) of these cases, including
two isolates of ST76, one isolate of ST902, and one isolate
of CC95. One isolate of ST2889 and one isolate of ST876
caused both meningitis and pneumonia at the same time.
TABLE 1. Disease types and antimicrobial resistance patterns of 68 invasive isolates of Streptococcus pneumoniae with
indicated serogroup or serotype
Serogroup or
serotype
(no. of isolates)
Bacteraemia
(n = 25)
Pneumonia
(n = 32)
Meninigitis
(n = 9)
Others
(n = 4)
Underlying
disease
(% of patients) Mortality
Penicillin
MIC >0.06 lg/mL
(% of isolates)
Cefotaxime
MIC > 0.5lg/mL
(% of isolates)
14 (23) 6 15a 2a 1 1 (4.3) 2 22 (95.7) 7 (30.4)
23F (12) 9 2 0 1 0 (0) 0 12 (100) 9 (75)
6B (11) 1 5 4 1 2 (18.1) 1 10 (90.9) 5 (45.5)
19F (9) 4 4 0 1 2 (22.2) 1 9 (100) 6 (66.7)
3 (4) 0 3 1 0 0 (0) 0 0 (0) 0 (0)
15 (3) 1 1b 2b 0 3 (100) 0 2 (66.7) 0 (0)
23A (2) 2 0 0 0 2 (100) 0 2 (100) 1 (50)
9V (1) 0 1 0 0 0 (0) 0 1 (100) 1 (100)
6A (1) 1 0 0 0 0 (0) 0 0 (0) 0 (0)
33 (1) 0 1 0 0 0 (0) 0 0 (0) 0 (0)
18C (1) 1 0 0 0 0 (0) 0 1 (100) 0 (0)
aOne isolate of serotype 14 caused both pneumonia and meningitis.
bOne isolate of serogroup 15 caused both pneumonia and meningitis.
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Antimicrobial resistance
Among the meningitis isolates, 77.8% were resistant to peni-
cillin (meningitis criteria). Among 59 non-meningitis isolates,
8.5% were intermediately resistant and 1.7% were resistant
to penicillin (non-meningitis criteria). CCs genetically related
to international clones accounted for 59.3% (35/59) of iso-
lates with a penicillin MIC value >0.06 lg/mL.
Among the meningitis isolates, 22.2% were resistant or
intermediately resistant to cefotaxime (meningitis criteria).
Among the non-meningitis isolates, 10.2% were intermedi-
ately resistant and 1.7% were resistant to cefotaxime (non-
meningitis criteria). CCs genetically related to international
clones accounted for 79.3% (23/29) of S. pneumoniae isolates
with a cefotaxime MIC value >0.5 lg/mL.
Among the 64 isolates, all were susceptible to vancomy-
cin, 92.2% (59/64) were susceptible to amoxycillin–clavula-
nate, and 95.3% (61/64) were resistant or intermediately
resistant to erythromycin.
The prevalence of the zmpC gene and the zmpD gene
among invasive isolates
Among the 68 isolates, one isolate (1.5%) contained the
zmpC gene, and 32 isolates (47.1%) contained the zmpD
gene. The prevalence rate of the zmpD gene among isolates
of serotype 14 was higher than among common serotypes,
including 6B, 23F and 19F (Table 2). The prevalence rates of
the zmpD gene among isolates causing pneumonia, meningi-
tis, bacteraemia or other diseases were not signiﬁcantly dif-
ferent, regardless of serotype. A total of six isolates within
CC338, CC166 and ST46 yielded a PCR product of approxi-
mately 5500 bp with the use of primers upper-zmpD and
down-zmpD. ZmpD genes in three isolates, each representing
CC338, CC166 and ST46, were sequenced for study of the
conservation of the zmpD gene. ClustalW analysis revealed
that the zmpD gene of G54 had 98% similarity with the
zmpD gene of 7301 representing CC338, 99% similarity with
the zmpD gene of WF39 representing CC166, and 97% simi-
larity with the zmpD gene of BT20 representing ST46 at the
DNA level. ZmpD of G54 had 97% similarity with ZmpD of
7301, 99% similarity with ZmpD of WF39 and 97% similarity
with ZmpD of BT20 at the amino acid level.
Discussion
Taiwan has been an area with a high prevalence of penicillin-
resistant S. pneumoniae for more than a decade [16–18]. This
study showed that the international clones England14 ST9,
TABLE 2. Clonal complex, multilocus sequence type (ST), serogroup/serotype, the presence of the zmpC gene and the zmpD
gene and antimicrobial susceptibility among 68 invasive isolates of Streptococcus pneumoniae
Clonal
complex
Serogroup or
serotype ST
zmpC gene
(% of isolates)
zmpD gene
(% of isolates)
Range of
penicillin MIC
(mg/L)
Range of
cefotaxime MIC
(mg/L)
Related PMEN
clone
13 (10) 14 9 (2) – 2 (100) 0.03–4 0.03–4 England14 ST9
13 (2)a – 2 (100) 2 0.5
2737 (1) – 1 (100) 2 1
2652 (4) – 4 (100) 1–2 0.5–2
1562 (1) – 1 (100) 1 0.5
236 (9) 19F 236 (7)a – – 1–4 0.5–1 Taiwan19F ST236
1170 (1) – – 2 0.25
2890 (1) – – 1 0.25
14 876 (8) – 7 (87.5) 1–2 0.5–1
81 (6) 23F 81 (2)a – 2 (100) 2 1 Spain23F ST81
83 (1) – 1 (100) 0.12 0.03
2395 (2) – 2 (100) 1–2 1
2891 (1) – 1 (100) 2 2
23F 242 (4) – – 1–4 0.5–2 Taiwan23F ST242
6B 902 (3) – – 0.06–4 0.06–1
95 (4) 6B 93 (1) – – 1 1 Spain6B ST95
95 (3) – 1 (33.3) 1–2 0.5–2
338 (3) 23A, 23F 338 (2) – 2 (100) 0.5–8 0.25–2 Colombia23F ST338
361 (1) – – 0.25 0.25
3 180 (4) – – 0.03 0.03–0.25
6B 76 (4) – – 1–2 0.5–1
166 (2) 9V, 14 166 (1) – 1 (100) 2 1 Spain9V-ST 156
1225 (1) – 1 (100) 2 1
15 2889 (3) – – 0.03–0.12 0.03–0.12
14 46 (4) – 4 (100) 0.12–0.25 0.12
6A 188 (1) – – 0.03 0.03
33 717 (1) 1 (100) – 0.03 0.03
23F 2921 (1) – – 2 1
18C 870 (1) – – 0.12 0.06
PMEN, Pneumococcal Molecular Epidemiology Network.
aFounder ST was within the clonal complex.
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Taiwan19F ST236, Spain23F ST81, Taiwan23F ST242 and
Colombia23F ST338, their variants and variants of Spain6B
ST95 have successfully spread throughout Taiwan. Data pro-
vided by the MLST database (http://www.mlst.net) revealed
that ST876, ST46, ST76 and ST2889 were ﬁrst identiﬁed as
penicillin-resistant clones in Taiwan, and indicated that these
penicillin-resistant clones continued to evolve de novo in
Taiwan and were disseminated among children, to causing
invasive disease.
England14 ST9 was recognized as a major clone with the
highest invasive disease potential in the UK [19,20]. Later,
similar ﬁndings were made in Italy [21], Spain [22], Sweden
[23], Greece [24], and even the USA [25]. The England14
ST9 clone was characterized as harbouring the mefA subclass
of the mef gene, resulting in the emergence of macrolide
resistance in S. pneumoniae in European countries [22]. Eng-
land14 ST9 was penicillin-susceptible in those European
countries [26,27], but evolved to express very high penicillin
MICs in the USA [25]. In Taiwan, isolates that were resistant
or intermediately resistant to penicillin and isolates that were
resistant or intermediately resistant to cefotaxime within
CC13 comprising ST9 and their variants were also found.
Given the high potential for evolution and invasiveness of
this clone, the need for continued molecular surveillance
cannot be overemphasized.
Shi et al. [28] showed that Spain23F ST81, Taiwan19F ST236
and Taiwan23F ST242 were three major clones of penicillin-
resistant S. pneumoniae between 1993 and 1997 in Taiwan.
These two Taiwan clones were presumed to have emerged
within the Far East in the 1990s, and then to have been dissem-
inated internationally [23,29,30]. These three antibiotic-
resistant clones remain predominant as threats to the health
of children in the community in Taiwan. Invasive isolates of
serotypes 19F and 23F were usually genetically diverse [31].
In the present study, isolates of serotype 23F consisted of
three CCs, whereas isolates of serotype 19F were all within a
single CC, CC236. Clonal expansion of Taiwan19F ST236
resulted in the emergence of penicillin-resistant serotype 19F
causing invasive pneumococcal disease in children in Taiwan. A
domestic clone, ST876, was the second largest cluster in
isolates of serotype 14. It is also interesting that ST876 is an
SLV of ST199, a dominant clone expressing non-vaccine sero-
type 19A in the post-conjugate vaccine era in the USA [5].
On the basis of the interactions between pneumococcal
capsular polysaccharides and the typing sera, 91 individual
serotypes are recognized in S. pneumoniae [32,33]. The diver-
sity of capsular polysaccharides of S. pneumoniae is thought
to be the consequence of selection for antigenic diversity
imposed by the human immune system [34]. Serotype 14 has
been shown to be the prevalent serotype associated with
invasive disease in numerous studies [17,31,35,36]. Compari-
son between S. pneumoniae isolates causing invasive diseases
and those from nasopharygeal carriage revealed that sero-
type 14 showed a high invasive disease potential [19]. Sero-
types 19F and 23F were considered to be carrier serotypes
with a lower relative risk that mainly infected patients with
underlying diseases [23,31]. In the present study, we
observed that serotype 14 was signiﬁcantly associated with
pneumonia, whereas serotype 23F was prone to cause bac-
teraemia in children. The association between serotypes and
disease types may be related to the nature of capsule or
other genetic factors that predispose certain serotypes to
spread among children. The ﬁnding that non-vaccine sero-
types were more frequently isolated from patients with
underlying diseases implies the need for supplemental pro-
tection with the 23-valent polysaccharide vaccine in addition
to the seven-valent conjugate vaccine.
Camilli et al. [11] demonstrated that isolates of serotypes
8 and 11A frequently harboured both the zmpC gene and
the zmpD gene in Italy. The present study of invasive isolates
in Taiwan found that the zmpC gene was rarely seen, and
the prevalence of the zmpD gene was high in serotype 14.
Furthermore, we observed that the zmpD gene was associ-
ated with three unrelated global clones (England14 ST9,
Spain23F ST81, and Spain9VST156), which might account for
the recent success of these clones.
In summary, speciﬁc resistant pneumococcal clones with
vaccine serotypes, either being introduced from other coun-
tries or evolving de novo, have been mainly responsible for
invasive disease among children in Taiwan. In view of the
wide dissemination of certain international antibiotic-resistant
clones with a high capability for adaption and evolution, the
seven-valent pneumococcal conjugate vaccine should be used
more widely in Taiwan.
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